Abbie M. Maguire, Ph.D.
Affiliations: | 2012-2017 | Molecular Biology, Cell Biology and Biochemistry | Brown University, Providence, RI |
| 2017- | Molecular Biology, Cell Biology and Biochemistry | Brown University, Providence, RI |
Google:
"Abbie Maguire"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Eric Morrow | grad student | 2012-2017 | Brown | |
| (Postdoctoral fellow as of May 2017) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leung CS, Rosenzweig S, Yoon B, et al. (2023) Dysregulation of the chromatin environment leads to differential alternative splicing as a mechanism of disease in a human model of autism spectrum disorder. Human Molecular Genetics |
| Lizarraga SB, Ma L, Maguire AM, et al. (2021) Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies. Science Translational Medicine. 13 |
| Bennett J, Wellman J, Marshall KA, et al. (2016) Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet (London, England) |
| Shah N, Damani MR, Zhu XS, et al. (2016) Isolated maculopathy associated with biallelic CRB1 mutations. Ophthalmic Genetics. 1-4 |
| Fuerst NM, Serrano L, Han G, et al. (2016) Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization. Ophthalmic Genetics. 1-8 |
| Gamsiz ED, Sciarra LN, Maguire AM, et al. (2015) Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 553-71 |
| Jacobson SG, Aleman TS, Cideciyan AV, et al. (2005) Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success. Proceedings of the National Academy of Sciences of the United States of America. 102: 6177-82 |